Cardiorenal organ protection is increasingly coming to the fore

Nowadays, the improvement of the cardiorenal prognosis in patients with type 2 diabetes is largely independent of the current metabolic situation. The focus of patient-oriented treatment is on quality of life and organ protection. This is reflected in the current recommendations of the European and US diabetes societies (EASD/ADA) and in the practical recommendations of the German Diabetes Association (DDG). In addition, the European Society of Cardiology (ESC) has published evidence-based guidelines for the cardiorenal management of type 2 diabetics.